YOLFTbeta
Scorpius Holdings Inc

Scorpius Holdings Inc

SCPX · AMEX · Healthcare / Biotechnology

0.0002USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.0002
Open0.01
Day Range0.01 – 0.0111
52-Week Range0.0001 – 0.04
Volume60.81K
Market Cap61.14K
P/E (TTM)0.00
Forward P/E0.00
EPS-4.18
Dividend Yield0.00%
Beta-4.97
50-Day Avg0.0014
200-Day Avg0.0038

About

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jeffrey Alan Wolf J.D.
  • Employees90
  • Headquarters1305 East Houston Street, San Antonio, TX, United States, 78205, USA
  • Websitehttps://www.scorpiusbiologics.com

Leadership

  • Mr. Jeffrey Alan Wolf J.D.Founder, Chairman, President & CEO · b. 1963
  • Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D.Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
  • Colonel George E. Peoples Jr., F.A.C.S., M.D.Chief Medical Advisor · b. 1963
  • Mr. Joe PaynePresident & COO of Scorpius BioManufacturing
  • Ms. Nicole TempleSenior Manager & Head of Program Management

Financials

Income Statement

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue187.79K3.11K---341.64K1.52M5.79M3.05M2.95M2.11M5.98M6.99M6.24M
Growth (%)--98.34%----+344.89%+281.19%-47.37%-3.32%-28.33%+183.08%+16.95%-10.75%
Cost of Revenue-253.19K1.40M5.25M116.00K9.33M8.27M16.23M13.01M12.94M691.48K6.40M9.21M3.20M
Gross Profit187.79K-250.08K-1.40M-5.25M-116.00K341.64K1.52M5.79M3.05M2.95M1.42M-420.02K-2.22M3.05M
Gross Margin100.00%-8041.13%---100.00%100.00%100.00%100.00%100.00%67.27%-7.02%-31.69%48.80%
Operating Expense2.22M2.09M5.17M6.94M20.91M13.47M14.64M23.26M22.44M29.07M36.84M45.27M39.82M36.65M
Operating Income-2.03M-2.34M-6.56M-12.19M-21.02M-13.13M-13.12M-17.46M-19.40M-26.12M-35.42M-45.69M-42.03M-33.60M
Operating Margin-1083.57%-75327.23%----3842.41%-863.10%-301.43%-636.11%-886.18%-1676.40%-763.90%-600.90%-538.21%
EBITDA-2.03M-2.34M-6.55M-12.08M-20.91M-12.29M-12.98M-17.23M-19.16M-24.59M-34.86M-39.29M-33.99M-26.22M
EBITDA Margin-1082.96%-75243.99%----3598.29%-854.27%-297.33%-628.48%-834.21%-1649.72%-656.97%-485.95%-420.00%
Net Income-2.10M-2.42M-8.71M-11.79M-20.30M-12.57M-11.84M-15.73M-20.02M-26.05M-35.07M-43.43M-45.22M-32.81M
Net Income Margin-1120.89%-77819.94%----3680.44%-779.09%-271.56%-656.51%-883.65%-1659.95%-726.21%-646.44%-525.51%
R&D1.25M902.94K2.74M2.86M16.67M9.33M8.27M16.23M13.01M12.94M16.46M23.46M20.12M14.33M
R&D as % of Total Revenue663.83%29033.38%---2731.12%543.94%280.18%426.80%438.91%778.84%392.27%287.64%229.49%
Interest Expense63.17K101.09K79.12K73.35K364.00K549.40K22.17K265.75K1.69M566.72K3.54M182.51K776.84K953.17K
Interest Expense % of Total Revenue33.64%3250.35%---160.81%1.46%4.59%55.58%19.22%167.56%3.05%11.11%15.27%

Balance Sheet

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets182.07K147.58K23.02M15.92M13.22M8.90M20.19M37.76M53.83M124.19M120.96M104.40M51.04M39.18M
Total Liabilities516.16K1.66M1.30M4.88M10.72M2.06M14.41M7.52M40.67M8.70M8.93M31.96M22.74M37.50M
Total Equity-334.10K-1.52M21.72M11.03M2.50M6.84M5.78M30.24M13.16M115.49M112.03M72.44M28.29M6.30M
Cash98.65K5.03K4.57M3.71M4.94M7.84M9.76M22.15M9.04M10.93M8.05M8.43M184.93K1.03M
Total Debt-922.10K-2.71M6.75M---1.93M1.85M1.93M9.39M14.04M28.55M
Net Debt-98.65K917.07K-4.57M-1.00M1.81M-7.84M-9.76M-22.15M-7.11M-9.08M-6.13M956.79K13.86M27.52M

Cash Flow

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow-1.65M-2.07M-6.39M-9.83M-17.45M-13.52M-6.30M-21.43M-12.79M-22.02M-38.13M-5.70M-31.53M-26.01M
Investing Cash Flow----3.75M6.61M-530.18K-6.16M-294.00K-95.42M9.77M10.99M32.24M1.21M
Financing Cash Flow1.58M1.98M28.35M3.01M15.01M9.80M8.77M40.12M19.05K119.33M25.49M-4.91M-8.95M25.64T
Capital Expenditure12.21K1.78K49.32K458.68K116.00K45.94K61.38K593.57K265.19K337.97K1.90M20.12M1.99M875.15K
Free Cash Flow-1.66M-2.08M-6.44M-10.29M-17.56M-13.57M-6.37M-22.02M-13.06M-22.36M-40.03M-25.82M-33.52M-26.88M
Dividends Paid---------97.05K----
FCF to OCF100.74%100.09%100.77%104.67%100.66%100.34%100.97%102.77%102.07%101.53%105.00%452.92%106.30%103.37%
Dividend Paid to FCF----------0.43%----

Earnings

Report DateSep 5, 2013Nov 14, 2013Mar 31, 2014May 12, 2014Aug 13, 2014Nov 14, 2014Mar 27, 2015May 14, 2015Aug 13, 2015Oct 30, 2015Feb 18, 2016May 11, 2016Aug 15, 2016Nov 10, 2016Mar 31, 2017May 11, 2017Aug 14, 2017Nov 13, 2017Mar 2, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 28, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 30, 2020May 15, 2020Aug 7, 2020Nov 9, 2020Mar 25, 2021May 5, 2021Aug 11, 2021Nov 10, 2021Mar 11, 2022May 16, 2022Aug 10, 2022Nov 14, 2022Mar 31, 2023May 15, 2023Aug 14, 2023Nov 20, 2023Mar 7, 2024Apr 26, 2024Aug 19, 2024Nov 18, 2024May 26, 2025Aug 22, 2025Jan 12, 2026
EPS Estimate-5320.00-15.75-4550.00-26.95-5530.00-5810.00-30.45-6860.00-6440.00-8540.00-9006.67-7840.00-3640.00-2100.00-4.90-2100.00-1400.00-1260.00-980.00-0.70-252.00-228.67-1.36-252.00-154.00-168.00-1.00-140.00-119.00-42.00-0.35-59.33-64.00-60.40-0.32-78.00-57.00-55.00-86.00-0.19-90.00-70.00-0.22-44.00---0.000.00
EPS Actual-12880.00-33.60-7912.80-25.20-6160.00-6440.00-39.20-7980.00-7840.00-8680.00-10920.00-7000.00-2380.00-1120.00-8.40-1680.00-1260.00-840.00-454.58-0.75-378.00-224.00-1.05-238.00-196.00-252.00-0.70-129.22-57.12-83.58-0.02-62.00-52.00-60.00-0.54-64.00-80.00-74.66-96.00-0.47-106.00-100.00-0.21-42.00-26.98-1.43-1.85-1.16-0.09
Surprise-142.11%-113.33%-73.91%6.49%-11.39%-10.84%-28.74%-16.33%-21.74%-1.64%-21.24%10.71%34.62%46.67%-71.43%20.00%10.00%33.33%53.61%-7.14%-50.00%2.04%22.79%5.56%-27.27%-50.00%30.00%7.70%52.00%-99.00%94.29%-4.50%18.75%0.66%-68.75%17.95%-40.35%-35.75%-11.63%-149.21%-17.78%-42.86%4.55%4.55%-----
TimingAfter-hours-After-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours--

Key Statistics & Ratios

Market Cap61.14K
Enterprise Value17.58M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.04
Price / Book0.11
EPS-4.18
Book Value-0.022
Revenue (TTM)1.72M
Gross Profit (TTM)-10.55M
EBITDA-21.76M
Profit Margin0.00%
Operating Margin-2056.82%
Return on Equity-303.40%
Return on Assets-47.94%
Shares Outstanding61.14M
Shares Float61.12M
Beta-4.97
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 5.00
  • Strong Buy
    1

Stock Splits

  • Jan 21, 20251:20
  • Jul 18, 20241:200
  • Dec 11, 20201:7
  • Jan 22, 20181:10